Dorsey Wright & Associates Reneo Pharmaceuticals, Inc. Transaction History
Dorsey Wright & Associates
- $403 Million
- Q4 2024
Shares
1 transactions
Others Institutions Holding RPHM
# of Institutions
4Shares Held
4.9MCall Options Held
0Put Options Held
0-
River Vest Venture Management LLC St. Louis, MO2.53MShares$4.26 Million63.0% of portfolio
-
Abingworth LLP London, X02.07MShares$3.48 Million1.6% of portfolio
-
Black Rock Inc. New York, NY294KShares$493,3330.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.53KShares$2,5630.0% of portfolio
About Reneo Pharmaceuticals, Inc.
- Ticker RPHM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,479,600
- Market Cap $41.1M
- Description
- Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...